Sukhatme Mayukh bought ROIV
February 9, 2026 · Form 4 insider transaction
Sukhatme Mayukh bought 651,558 shares of Roivant Sciences Ltd. at $12.68 per share, a transaction worth $8.26M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
651,558
Price
$12.68
Total value
$8.26M
InsiderSukhatme Mayukh
RoleOfficer, Director
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateFebruary 9, 2026
Filing dateFebruary 11, 2026
Shares owned after19,488,105
OwnershipDirect
10b5-1 planNo
AmendedNo